Kabelline Contouring Serum
- Bulk Discount From 5 PCS
- Get 5% extra discount by using WISE or Bank Transfer
Kabelline — injection lipolysis formula for non-surgical contouring of the face and body. Targets stubborn fat deposits for a more sculpted appearance. 8 ml × 5 vials. For professional use.
$51.50
| Quantity | Discount | Price |
|---|---|---|
| 5-9 | 3% | $49.96 |
| 10-19 | 5% | $48.93 |
| 20-Unlimited | 8% | $47.38 |
Kabelline is a fat-dissolving contouring solution built around deoxycholic acid together with L-carnitine and peptides. It takes a gentler approach to lipolysis: a lower-concentration deoxycholic acid for safety, L-carnitine to support fat metabolism, and peptides to help maintain skin firmness. KFDA approved and used for facial and small-area body contouring.
How Kabelline works
Kabelline’s formulation philosophy is a gentler, balanced one. Rather than rapid, aggressive dissolution, it uses a lower concentration of deoxycholic acid for safety, with L-carnitine to support the body’s fat metabolism and peptides to address skin laxity after treatment. This suits precise contouring of areas such as the double chin and small body zones.
What’s in Kabelline
Deoxycholic acid (gentle level).
Deoxycholic acid is a bile-acid surfactant that disrupts fat-cell membranes. Kabelline uses it at a lower concentration for a gentler, safety-focused approach to fat reduction.
L-carnitine.
L-carnitine helps transport fatty acids for metabolism, supporting the fat-reduction effect and compensating for the gentler deoxycholic-acid level.
Peptide complex.
Peptides help address potential post-procedure skin laxity, supporting firmness and tone in the treated area.
Treatment & protocol
Treatment focus
Specifications
Frequently asked questions
What is Kabelline?
A fat-dissolving contouring solution of deoxycholic acid with L-carnitine and peptides, taking a gentler, safety-focused approach to lipolysis. It is KFDA approved.
How is Kabelline different from stronger fat dissolvers?
It uses a lower concentration of deoxycholic acid for safety, with L-carnitine to support metabolism and peptides for skin firmness — a gentler approach rather than rapid dissolution.
Is Kabelline FDA approved?
Kabelline is KFDA approved in South Korea. Deoxycholic acid as a material has US FDA approval in other products, but that does not mean Kabelline itself is US-FDA approved — confirm current status for your market.
Is it a weight-loss treatment?
No — it is for contouring localized fat, such as a double chin or small body areas, not for weight loss.
Which areas is Kabelline best for?
Facial contouring such as the double chin and jawline, and small stubborn body areas.
How many sessions are needed?
Typically around 3–8 sessions; facial areas often need fewer than body areas, as decided by the practitioner.
Is some swelling normal?
Mild swelling or tenderness can occur after treatment and usually settles; follow your practitioner’s after-care.
Who can administer Kabelline?
Licensed, trained practitioners only, using correct injection technique.
Related fat-dissolving products
Safety information
This is an injectable medical-aesthetic treatment for use by licensed practitioners only, administered as point injections into the subcutaneous fat. It is intended for contouring of localized fat, not for weight loss, and works best alongside a healthy diet and exercise. A course of sessions is usually needed and individual results vary. Mild swelling, redness, bruising or tenderness at the injection sites is common and usually settles. Do not use over active infection or inflammation, in pregnancy or breastfeeding, or in patients with known hypersensitivity to the ingredients. Do not inject intramuscularly or intravenously. Refer to the manufacturer’s instructions for use and assess each patient before treatment.
Kabelline is a trademark of its respective brand owner. For licensed healthcare professionals only. Last reviewed: June 2026.
Related Products
INNO-TDS Face Nade Formula 4231
A face-specific contour formula for buyers who need a clearer story than a one-size-fits-all contour product. INNO-TDS Face Nade Formula 4231 combines six named actives in a professional 4 × 2.5 mL presentation, positioned around facial definition and firmer, more toned-looking skin.
- Dedicated facial-contour positioning
- Carnitine, Cynara, Melilotus, Tyrosine, Lecithin and Troxerutin
- Four 2.5 mL vials per box
A strong portfolio fit for clinics and distributors building a more concern-led facial contour range. Product selection and outcomes depend on professional assessment; follow the supplied label and local requirements.
Free Gift – PDRN Booster (1, Random)
Free Gift – Hyalmass Aqua Exosome (1 )
Wegovy Korean Version
Wegovy® (semaglutide), an GLP-1 receptor agonist, treats obesity (BMI≥30) or overweight (BMI≥27) with comorbidities like hypertension. In 68-week trials, patients achieved 15% mean weight loss (35 lb from 232 lb baseline), with 86% losing ≥5% and 30% ≥20%. Regulates hypothalamic appetite signals and delays gastric emptying for sustained effects. Features a 5-step dose escalation protocol (20 weeks) to minimize GI intolerance, while improving BP, lipids, and HbA1c for long-term weight maintenance.
Slim Point-Face
Slim Point Face is a rtified injectable solution for facial contouring, clinically proven to reduce submental fat by 15-22% in 4 weeks. Its dual-action enzymatic formula (Bromelain 800 IU/ml, Lecithin 5%) accelerates fat metabolism by 40%, reduces edema by 60%, and boosts collagen by 30% for toned, lifted skin with 2-4mm fat layer reduction per session.
Lipo Lab PPC Solution
Lipo Lab PPC Solution by CSBIO Inc. (South Korea) is an injectable for targeted fat reduction, clinically shown to reduce subcutaneous fat by 82% in treated areas (e.g., double chin, thighs) within 8 weeks. Its 50-70nm PPC/Sodium Deoxycholate formula emulsifies fat lls while boosting skin elasticity by 40%, with visible results in 2-4 weeks.
Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More


Reviews
Clear filtersThere are no reviews yet.